# Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease

> **NCT04326465** · NA · COMPLETED · sponsor: **University of British Columbia** · enrollment: 5 (actual)

## Conditions studied

- Peyronies Disease

## Interventions

- **DEVICE:** Fractional Carbon Dioxide Laser Therapy at 10-15% Laser Density Coverage

## Key facts

- **NCT ID:** NCT04326465
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326465, "Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04326465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*